Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration sort icon Public title Sponsor State
05/06/2020 Rectal Ozone in the COVID-19 treatment CPN Registered outdated
05/08/2014 CIMAVax EGF in Lung Cancer in PHC. Phase IV CIM Registered
05/08/2021 An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib ROCHE Registered
05/08/2021 Lithium Carbonate-COVID-19- mild and moderate -Exploratory / Phase II ICBPGirón Registered outdated
05/09/2017 CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma CIM Registered
05/10/2018 Nimotuzumab cold kit for the immunodiagnosis of solid tumors CIM Registered
05/11/2013 RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma CIM Registered outdated
06/01/2023 IVD in colon cancer HHA Registered
06/04/2021 Efectiveness- hypnotherapy- depressed patients UCMSC Registered
06/07/2023 Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock CIGB Registered
06/08/2014 Heptavalent Conjugate Vaccine against Pneumococcal (VCN7-T) in healthy children. CQB Registered
06/08/2020 Transfer factor in Chronic Kidney Disease CIGB Registered outdated
06/08/2020 A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America ROCHE Registered
06/11/2014 Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . FINLAY Registered
06/11/2020 Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2 CPN Registered outdated
06/12/2022 Nasal recombinant human interferon alfa-2b in ARI CIGB Registered
06/12/2022 Prebiotics and probiotics in the treatment of type 2 diabetes HHA Registered
07/03/2018 14F7 in chronic B-cell lymphoproliferative syndrome CIM Registered
07/03/2024 Quality of Life and safety of the nutritional supplement Deprexil® or Placebo in combination with cognitive stimulation treatment in patients with Mild Cognitive Impairment and Mild Alzheimer's Dementia. CATALYSIS Registered
07/08/2018 AMIGOS-2 study CIGB Registered outdated